The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...
Dec 29, 2022
0
14
In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antiretroviral drugs ...
Dec 9, 2022
0
15
Antiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV incidence such as Tanzania, according to a new study in The Lancet HIV ...
Dec 7, 2022
0
505
For people living with HIV, sticking to a prescribed medication regimen is a critical part of staying healthy. However, having to deal with the side effects caused by those medications—nausea and dizziness among them—can ...
Nov 11, 2022
0
48
HIV remains a major public health challenge globally. Around 38 million people are estimated to be living with the infection. Sub-Saharan Africa bears the brunt of the HIV epidemic. Close to two thirds of the HIV cases are ...
Sep 6, 2022
0
7
When expensive medicines that are proven to prevent HIV acquisition are available through employer-sponsored health insurance (ESI), annual earnings for men in same-sex couples decline and part-time employment increases. ...
Aug 17, 2022
0
48
Large-scale HIV screening and peer support to connect people who inject drugs to HIV care successfully reduced uncontrolled HIV in this population by more than 40 percent, according to a new study conducted in Haiphong, Vietnam.
Jul 19, 2022
0
50
Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system. Scientists at Scripps Research and collaborators have now uncovered how our innate immune system—the ...
Jul 8, 2022
0
70
Antiretroviral therapy has made HIV a manageable condition, but it does not eliminate the virus from the body—and most regimens are expensive and require a pill every day, for the rest of the patient's life.
Apr 19, 2022
0
28
University of Oxford researchers assessed evidence from 34 studies, involving more than 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of ...
Apr 12, 2022
0
30
